THE BIOECONOMY SUMMIT BRINGS TOGETHER THE PEOPLE BUILDING, FINANCING, AND DEPLOYING THE NEXT GENERATION OF BIOINDUSTRIAL CAPACITY.

The United States leads in bioindustrial innovation, but the ability to scale into deployed industrial capacity will determine the next decade of global competitiveness.

Across industrial biotechnology, the United States continues to lead in innovation, yet struggles to consistently translate that advantage into scaled production and critical mass. The challenge is no longer scientific discovery, it is execution at industrial scale.

Too often, promising technologies stall in the transition from pilot to commercial deployment. The constraints are well known: capital-intensive infrastructure, fragmented supply chains, financing gaps, infrastructure readiness, and weak or inconsistent demand signals. These are not isolated bottlenecks, but system-level friction points that determine whether innovation becomes industry.

Meanwhile, global competitors are making sustained, coordinated investments in biomanufacturing capacity and end-to-end supply chains, accelerating their ability to deploy at scale.

The Bioeconomy Summit focuses on execution and brings together the stakeholders directly responsible for making scale happen: those building facilities, financing infrastructure, shaping procurement strategy, and enabling deployment pathways.

Discussions will focus on the real constraints to scale – feedstocks, unit economics, logistics, infrastructure, and procurement – and on the mechanisms that can unlock faster commercialization and more durable market formation.

The goal is to move from isolated successes to repeatable industrial scale, and to strengthen the domestic capacity needed to consistently build and deploy bioindustrial systems at scale.

Co-located within the broader TechConnect event ecosystem, the Bioeconomy Summit offers expanded access to cross-sector partners, funding pathways, and real-world deployment opportunities.